VELIA BONILLA: Open Payments
NPI 1629680244 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 30 payments from 14 companies in 2025. Trend: 2023 $510 · 2024 $588 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $104 |
| PFIZER INC. | 4 | $72 |
| Amgen Inc. | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| Lilly USA, LLC | 3 | $49 |
| Exact Sciences Corporation | 3 | $47 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| Dexcom, Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: NURTEC ODT, OTEZLA, Kerendia, Rybelsus, Cologuard Collection Kit, GEMTESA, JARDIANCE, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
